Cascadian Therapeutics, Inc. Research and Development Expense
Cascadian Therapeutics, Inc. reported Research and Development Expense of $43.98 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2018-03-08
- Cascadian Therapeutics, Inc. research and development expense for the quarter ending 2017-12-31 was $12.97M, a 73.64% increase year-over-year.
- Cascadian Therapeutics, Inc. research and development expense for the quarter ending 2017-09-30 was $10.91M, a 49.84% increase year-over-year.
- Cascadian Therapeutics, Inc. research and development expense for the quarter ending 2017-06-30 was $11.51M, a 80.47% increase year-over-year.
- Cascadian Therapeutics, Inc. research and development expense for the quarter ending 2017-03-31 was $8.59M, a 35.51% increase year-over-year.
- Cascadian Therapeutics, Inc. research and development expense for fiscal 2017 was $43.98M, a 60.12% increase from fiscal 2016.
- Cascadian Therapeutics, Inc. research and development expense for fiscal 2016 was $27.47M, a 17.04% increase from fiscal 2015.
- Cascadian Therapeutics, Inc. research and development expense for fiscal 2015 was $23.47M, a 43.97% decline from fiscal 2014.
- Cascadian Therapeutics, Inc. research and development expense for fiscal 2014 was $41.88M, a 26.08% increase from fiscal 2013.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2017-12-31 | $12.97M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $23.88M derived: sum of 2 quarters · filed 2018-03-08 | $35.39M derived: sum of 3 quarters · filed 2018-03-08 | $43.98M 10-K · filed 2018-03-08 |
| 2017-09-30 | $10.91M 10-Q · filed 2017-11-08 | $22.42M derived: sum of 2 quarters · filed 2017-11-08 | $31.01M 10-Q · filed 2017-11-08 | $38.48M derived: sum of 4 quarters · filed 2018-03-08 |
| 2017-06-30 | $11.51M 10-Q · filed 2017-08-08 | $20.10M 10-Q · filed 2017-08-08 | $27.57M derived: sum of 3 quarters · filed 2018-03-08 | $34.85M derived: sum of 4 quarters · filed 2018-03-08 |
| 2017-03-31 | $8.59M 10-Q · filed 2017-05-09 | $16.06M derived: sum of 2 quarters · filed 2018-03-08 | $23.34M derived: sum of 3 quarters · filed 2018-03-08 | $29.72M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-12-31 | $7.47M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $14.75M derived: sum of 2 quarters · filed 2018-03-08 | $21.13M derived: sum of 3 quarters · filed 2018-03-08 | $27.47M 10-K · filed 2018-03-08 |
| 2016-09-30 | $7.28M 10-Q · filed 2017-11-08 | $13.66M derived: sum of 2 quarters · filed 2017-11-08 | $20.00M 10-Q · filed 2017-11-08 | $26.89M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $6.38M 10-Q · filed 2017-08-08 | $12.72M 10-Q · filed 2017-08-08 | $19.60M derived: sum of 3 quarters · filed 2018-03-08 | $24.73M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | $6.34M 10-Q · filed 2017-05-09 | $13.22M derived: sum of 2 quarters · filed 2018-03-08 | $18.35M derived: sum of 3 quarters · filed 2018-03-08 | $24.05M derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | $6.89M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $12.01M derived: sum of 2 quarters · filed 2018-03-08 | $17.71M derived: sum of 3 quarters · filed 2018-03-08 | $23.47M 10-K · filed 2018-03-08 |
| 2015-09-30 | $5.12M 10-Q · filed 2016-11-07 | $10.82M derived: sum of 2 quarters · filed 2016-11-07 | $16.58M 10-Q · filed 2016-11-07 | $42.59M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-06-30 | $5.70M 10-Q · filed 2016-08-08 | $11.46M 10-Q · filed 2016-08-08 | $37.47M derived: sum of 3 quarters · filed 2017-03-09 | $43.13M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-03-31 | $5.76M 10-Q · filed 2016-05-09 | $31.77M derived: sum of 2 quarters · filed 2017-03-09 | $37.43M derived: sum of 3 quarters · filed 2017-03-09 | $42.83M derived: sum of 4 quarters · filed 2017-03-09 |
| 2014-12-31 | $26.01M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $31.67M derived: sum of 2 quarters · filed 2017-03-09 | $37.07M derived: sum of 3 quarters · filed 2017-03-09 | $41.88M 10-K · filed 2017-03-09 |
| 2014-09-30 | $5.66M 10-Q · filed 2015-11-05 | $11.06M derived: sum of 2 quarters · filed 2015-11-05 | $15.88M 10-Q · filed 2015-11-05 | $21.72M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $5.40M 10-Q · filed 2015-08-06 | $10.21M 10-Q · filed 2015-08-06 | $16.06M derived: sum of 3 quarters · filed 2016-03-14 | $21.58M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $4.81M 10-Q · filed 2014-05-01 | $10.66M derived: sum of 2 quarters · filed 2016-03-14 | $16.18M derived: sum of 3 quarters · filed 2016-03-14 | $32.23M derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $5.85M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $11.36M derived: sum of 2 quarters · filed 2016-03-14 | $27.42M derived: sum of 3 quarters · filed 2016-03-14 | $33.22M 10-K · filed 2016-03-14 |
| 2013-09-30 | $5.52M 10-Q · filed 2014-11-06 | $21.57M derived: sum of 2 quarters · filed 2014-11-06 | $27.37M 10-Q · filed 2014-11-06 | $33.03M derived: sum of 4 quarters · filed 2015-03-10 |
| 2013-06-30 | $16.06M 10-Q · filed 2014-08-11 | $21.86M 10-Q · filed 2014-08-11 | $27.51M derived: sum of 3 quarters · filed 2015-03-10 | $33.29M derived: sum of 4 quarters · filed 2015-03-10 |
| 2013-03-31 | $5.80M 10-Q · filed 2014-05-01 | $11.45M derived: sum of 2 quarters · filed 2015-03-10 | $17.23M derived: sum of 3 quarters · filed 2015-03-10 | $23.51M derived: sum of 4 quarters · filed 2015-03-10 |
| 2012-12-31 | $5.65M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-10 | $11.44M derived: sum of 2 quarters · filed 2015-03-10 | $17.71M derived: sum of 3 quarters · filed 2015-03-10 | $22.00M 10-K · filed 2015-03-10 |
| 2012-09-30 | $5.78M 10-Q · filed 2013-11-12 | $12.06M derived: sum of 2 quarters · filed 2013-11-12 | $16.35M 10-Q · filed 2013-11-12 | $20.50M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-06-30 | $6.28M 10-Q · filed 2013-08-06 | $10.56M 10-Q · filed 2013-08-06 | $14.72M derived: sum of 3 quarters · filed 2014-03-13 | $20.10M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-03-31 | $4.29M 10-Q · filed 2013-05-09 | $8.44M derived: sum of 2 quarters · filed 2014-03-13 | $13.82M derived: sum of 3 quarters · filed 2014-03-13 | $18.01M derived: sum of 4 quarters · filed 2014-03-13 |
| 2011-12-31 | $4.15M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $9.53M derived: sum of 2 quarters · filed 2014-03-13 | $13.73M derived: sum of 3 quarters · filed 2014-03-13 | $17.91M 10-K · filed 2014-03-13 |
| 2011-09-30 | $5.38M 10-Q · filed 2012-11-07 | $9.58M derived: sum of 2 quarters · filed 2012-11-07 | $13.76M 10-Q · filed 2012-11-07 | $17.22M derived: sum of 4 quarters · filed 2013-03-14 |
| 2011-06-30 | $4.19M 10-Q · filed 2012-08-13 | $8.38M 10-Q · filed 2012-08-13 | $11.83M derived: sum of 3 quarters · filed 2013-03-14 | $14.51M derived: sum of 4 quarters · filed 2013-03-14 |
| 2011-03-31 | $4.19M 10-Q/A · filed 2012-08-13 | $7.64M derived: sum of 2 quarters · filed 2013-03-14 | $10.32M derived: sum of 3 quarters · filed 2013-03-14 | $13.18M derived: sum of 4 quarters · filed 2013-03-14 |
| 2010-12-31 | $3.45M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $6.13M derived: sum of 2 quarters · filed 2013-03-14 | $8.99M derived: sum of 3 quarters · filed 2013-03-14 | $11.60M 10-K · filed 2013-03-14 |
| 2010-09-30 | $2.68M 10-Q · filed 2011-11-08 | $5.54M derived: sum of 2 quarters · filed 2011-11-08 | $8.15M 10-Q · filed 2011-11-08 | |
| 2010-06-30 | $2.86M 10-Q · filed 2011-08-08 | $5.47M 10-Q · filed 2011-08-08 | ||
| 2009-12-31 | $6.21M 10-K/A · filed 2012-08-13 |